nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—Doxorubicin—bone cancer	0.972	1	CbGbCtD
Lubiprostone—Pain—Carboplatin—bone cancer	0.000637	0.0232	CcSEcCtD
Lubiprostone—Cramp muscle—Cisplatin—bone cancer	0.0004	0.0146	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.0004	0.0146	CcSEcCtD
Lubiprostone—Abdominal discomfort—Cisplatin—bone cancer	0.000368	0.0134	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Epirubicin—bone cancer	0.000348	0.0127	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Doxorubicin—bone cancer	0.000322	0.0117	CcSEcCtD
Lubiprostone—Eructation—Epirubicin—bone cancer	0.000309	0.0112	CcSEcCtD
Lubiprostone—Connective tissue disorder—Cisplatin—bone cancer	0.000302	0.011	CcSEcCtD
Lubiprostone—Eructation—Doxorubicin—bone cancer	0.000286	0.0104	CcSEcCtD
Lubiprostone—Mediastinal disorder—Cisplatin—bone cancer	0.000277	0.0101	CcSEcCtD
Lubiprostone—Erythema—Cisplatin—bone cancer	0.000268	0.00975	CcSEcCtD
Lubiprostone—Malnutrition—Cisplatin—bone cancer	0.000268	0.00975	CcSEcCtD
Lubiprostone—Flatulence—Cisplatin—bone cancer	0.000264	0.0096	CcSEcCtD
Lubiprostone—Muscle spasms—Cisplatin—bone cancer	0.000257	0.00937	CcSEcCtD
Lubiprostone—Tremor—Cisplatin—bone cancer	0.000251	0.00913	CcSEcCtD
Lubiprostone—Lethargy—Methotrexate—bone cancer	0.000249	0.00906	CcSEcCtD
Lubiprostone—Ill-defined disorder—Cisplatin—bone cancer	0.000248	0.00904	CcSEcCtD
Lubiprostone—Malaise—Cisplatin—bone cancer	0.000241	0.00879	CcSEcCtD
Lubiprostone—Lethargy—Epirubicin—bone cancer	0.000233	0.00848	CcSEcCtD
Lubiprostone—Myalgia—Cisplatin—bone cancer	0.000228	0.0083	CcSEcCtD
Lubiprostone—Anxiety—Cisplatin—bone cancer	0.000227	0.00827	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000226	0.00824	CcSEcCtD
Lubiprostone—Discomfort—Cisplatin—bone cancer	0.000225	0.0082	CcSEcCtD
Lubiprostone—Oedema—Cisplatin—bone cancer	0.000219	0.00795	CcSEcCtD
Lubiprostone—Lethargy—Doxorubicin—bone cancer	0.000216	0.00785	CcSEcCtD
Lubiprostone—Nervous system disorder—Cisplatin—bone cancer	0.000214	0.0078	CcSEcCtD
Lubiprostone—Tachycardia—Cisplatin—bone cancer	0.000213	0.00776	CcSEcCtD
Lubiprostone—Skin disorder—Cisplatin—bone cancer	0.000212	0.00773	CcSEcCtD
Lubiprostone—Hyperhidrosis—Cisplatin—bone cancer	0.000211	0.00769	CcSEcCtD
Lubiprostone—Anorexia—Cisplatin—bone cancer	0.000208	0.00758	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000206	0.00748	CcSEcCtD
Lubiprostone—Abdominal discomfort—Methotrexate—bone cancer	0.000202	0.00736	CcSEcCtD
Lubiprostone—Gastritis—Epirubicin—bone cancer	0.000202	0.00735	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000201	0.00733	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000199	0.00725	CcSEcCtD
Lubiprostone—Abdominal distension—Epirubicin—bone cancer	0.000199	0.00723	CcSEcCtD
Lubiprostone—Influenza—Epirubicin—bone cancer	0.000197	0.00718	CcSEcCtD
Lubiprostone—Dyspnoea—Cisplatin—bone cancer	0.000195	0.00709	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00019	0.00692	CcSEcCtD
Lubiprostone—Decreased appetite—Cisplatin—bone cancer	0.00019	0.00691	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000189	0.00687	CcSEcCtD
Lubiprostone—Gastritis—Doxorubicin—bone cancer	0.000187	0.00681	CcSEcCtD
Lubiprostone—Pain—Cisplatin—bone cancer	0.000187	0.0068	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000186	0.00678	CcSEcCtD
Lubiprostone—Abdominal distension—Doxorubicin—bone cancer	0.000184	0.00669	CcSEcCtD
Lubiprostone—Influenza—Doxorubicin—bone cancer	0.000183	0.00665	CcSEcCtD
Lubiprostone—Pollakiuria—Epirubicin—bone cancer	0.000182	0.00664	CcSEcCtD
Lubiprostone—Feeling abnormal—Cisplatin—bone cancer	0.00018	0.00655	CcSEcCtD
Lubiprostone—Weight increased—Epirubicin—bone cancer	0.00018	0.00654	CcSEcCtD
Lubiprostone—Urinary tract infection—Epirubicin—bone cancer	0.000171	0.00623	CcSEcCtD
Lubiprostone—Pollakiuria—Doxorubicin—bone cancer	0.000169	0.00614	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—bone cancer	0.000166	0.00605	CcSEcCtD
Lubiprostone—Hypersensitivity—Cisplatin—bone cancer	0.000161	0.00586	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—bone cancer	0.000158	0.00576	CcSEcCtD
Lubiprostone—Asthenia—Cisplatin—bone cancer	0.000157	0.00571	CcSEcCtD
Lubiprostone—Oedema peripheral—Epirubicin—bone cancer	0.000156	0.00566	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—bone cancer	0.000155	0.00565	CcSEcCtD
Lubiprostone—Mediastinal disorder—Methotrexate—bone cancer	0.000152	0.00554	CcSEcCtD
Lubiprostone—Diarrhoea—Cisplatin—bone cancer	0.00015	0.00544	CcSEcCtD
Lubiprostone—Mental disorder—Methotrexate—bone cancer	0.000148	0.00538	CcSEcCtD
Lubiprostone—Erythema—Methotrexate—bone cancer	0.000147	0.00535	CcSEcCtD
Lubiprostone—Malnutrition—Methotrexate—bone cancer	0.000147	0.00535	CcSEcCtD
Lubiprostone—Oedema peripheral—Doxorubicin—bone cancer	0.000144	0.00524	CcSEcCtD
Lubiprostone—Dysgeusia—Methotrexate—bone cancer	0.000144	0.00524	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—bone cancer	0.000144	0.00523	CcSEcCtD
Lubiprostone—Mediastinal disorder—Epirubicin—bone cancer	0.000142	0.00518	CcSEcCtD
Lubiprostone—Vomiting—Cisplatin—bone cancer	0.000139	0.00506	CcSEcCtD
Lubiprostone—Mental disorder—Epirubicin—bone cancer	0.000138	0.00504	CcSEcCtD
Lubiprostone—Rash—Cisplatin—bone cancer	0.000138	0.00501	CcSEcCtD
Lubiprostone—Dermatitis—Cisplatin—bone cancer	0.000138	0.00501	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—bone cancer	0.000138	0.005	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—bone cancer	0.000138	0.005	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methotrexate—bone cancer	0.000136	0.00496	CcSEcCtD
Lubiprostone—Flatulence—Epirubicin—bone cancer	0.000136	0.00493	CcSEcCtD
Lubiprostone—Dysgeusia—Epirubicin—bone cancer	0.000135	0.0049	CcSEcCtD
Lubiprostone—Malaise—Methotrexate—bone cancer	0.000133	0.00482	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—bone cancer	0.000132	0.00481	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—bone cancer	0.000132	0.00479	CcSEcCtD
Lubiprostone—Nausea—Cisplatin—bone cancer	0.00013	0.00472	CcSEcCtD
Lubiprostone—Cough—Methotrexate—bone cancer	0.000128	0.00467	CcSEcCtD
Lubiprostone—Mental disorder—Doxorubicin—bone cancer	0.000128	0.00466	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—bone cancer	0.000128	0.00464	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—bone cancer	0.000127	0.00463	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—bone cancer	0.000127	0.00463	CcSEcCtD
Lubiprostone—Flatulence—Doxorubicin—bone cancer	0.000125	0.00456	CcSEcCtD
Lubiprostone—Chest pain—Methotrexate—bone cancer	0.000125	0.00455	CcSEcCtD
Lubiprostone—Myalgia—Methotrexate—bone cancer	0.000125	0.00455	CcSEcCtD
Lubiprostone—Dysgeusia—Doxorubicin—bone cancer	0.000125	0.00453	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000124	0.00452	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—bone cancer	0.000124	0.00451	CcSEcCtD
Lubiprostone—Discomfort—Methotrexate—bone cancer	0.000124	0.0045	CcSEcCtD
Lubiprostone—Syncope—Epirubicin—bone cancer	0.000123	0.00449	CcSEcCtD
Lubiprostone—Muscle spasms—Doxorubicin—bone cancer	0.000122	0.00445	CcSEcCtD
Lubiprostone—Palpitations—Epirubicin—bone cancer	0.000122	0.00442	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—bone cancer	0.000121	0.0044	CcSEcCtD
Lubiprostone—Cough—Epirubicin—bone cancer	0.00012	0.00437	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—bone cancer	0.000118	0.0043	CcSEcCtD
Lubiprostone—Nervous system disorder—Methotrexate—bone cancer	0.000118	0.00428	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—bone cancer	0.000117	0.00426	CcSEcCtD
Lubiprostone—Myalgia—Epirubicin—bone cancer	0.000117	0.00426	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—bone cancer	0.000117	0.00425	CcSEcCtD
Lubiprostone—Skin disorder—Methotrexate—bone cancer	0.000116	0.00424	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000116	0.00423	CcSEcCtD
Lubiprostone—Hyperhidrosis—Methotrexate—bone cancer	0.000116	0.00422	CcSEcCtD
Lubiprostone—Discomfort—Epirubicin—bone cancer	0.000116	0.00421	CcSEcCtD
Lubiprostone—Malaise—Doxorubicin—bone cancer	0.000115	0.00418	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—bone cancer	0.000115	0.00417	CcSEcCtD
Lubiprostone—Anorexia—Methotrexate—bone cancer	0.000114	0.00416	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—bone cancer	0.000114	0.00415	CcSEcCtD
Lubiprostone—Palpitations—Doxorubicin—bone cancer	0.000112	0.00409	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—bone cancer	0.000112	0.00408	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—bone cancer	0.000112	0.00407	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—bone cancer	0.000111	0.00404	CcSEcCtD
Lubiprostone—Shock—Epirubicin—bone cancer	0.00011	0.00402	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—bone cancer	0.00011	0.00401	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—bone cancer	0.00011	0.00399	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000109	0.00398	CcSEcCtD
Lubiprostone—Skin disorder—Epirubicin—bone cancer	0.000109	0.00397	CcSEcCtD
Lubiprostone—Hyperhidrosis—Epirubicin—bone cancer	0.000109	0.00395	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—bone cancer	0.000108	0.00394	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—bone cancer	0.000108	0.00394	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—bone cancer	0.000108	0.00393	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000108	0.00392	CcSEcCtD
Lubiprostone—Discomfort—Doxorubicin—bone cancer	0.000107	0.0039	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—bone cancer	0.000107	0.00389	CcSEcCtD
Lubiprostone—Dyspnoea—Methotrexate—bone cancer	0.000107	0.00389	CcSEcCtD
Lubiprostone—Dry mouth—Doxorubicin—bone cancer	0.000106	0.00386	CcSEcCtD
Lubiprostone—Dyspepsia—Methotrexate—bone cancer	0.000106	0.00384	CcSEcCtD
Lubiprostone—Decreased appetite—Methotrexate—bone cancer	0.000104	0.00379	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—bone cancer	0.000104	0.00378	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000104	0.00377	CcSEcCtD
Lubiprostone—Fatigue—Methotrexate—bone cancer	0.000103	0.00376	CcSEcCtD
Lubiprostone—Pain—Methotrexate—bone cancer	0.000103	0.00373	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000102	0.00372	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—bone cancer	0.000102	0.00372	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—bone cancer	0.000102	0.00371	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—bone cancer	0.000101	0.00369	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—bone cancer	0.000101	0.00367	CcSEcCtD
Lubiprostone—Hyperhidrosis—Doxorubicin—bone cancer	0.0001	0.00365	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—bone cancer	0.0001	0.00364	CcSEcCtD
Lubiprostone—Anorexia—Doxorubicin—bone cancer	9.9e-05	0.0036	CcSEcCtD
Lubiprostone—Feeling abnormal—Methotrexate—bone cancer	9.88e-05	0.0036	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—bone cancer	9.88e-05	0.0036	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methotrexate—bone cancer	9.81e-05	0.00357	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—bone cancer	9.76e-05	0.00355	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Epirubicin—bone cancer	9.69e-05	0.00353	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—bone cancer	9.68e-05	0.00352	CcSEcCtD
Lubiprostone—Pain—Epirubicin—bone cancer	9.6e-05	0.00349	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—bone cancer	9.6e-05	0.00349	CcSEcCtD
Lubiprostone—Abdominal pain—Methotrexate—bone cancer	9.48e-05	0.00345	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.46e-05	0.00344	CcSEcCtD
Lubiprostone—Dyspnoea—Doxorubicin—bone cancer	9.26e-05	0.00337	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—bone cancer	9.25e-05	0.00337	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Epirubicin—bone cancer	9.18e-05	0.00334	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—bone cancer	9.14e-05	0.00333	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—bone cancer	9.03e-05	0.00329	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—bone cancer	8.97e-05	0.00326	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—bone cancer	8.95e-05	0.00326	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—bone cancer	8.88e-05	0.00323	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—bone cancer	8.88e-05	0.00323	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—bone cancer	8.87e-05	0.00323	CcSEcCtD
Lubiprostone—Hypersensitivity—Methotrexate—bone cancer	8.84e-05	0.00322	CcSEcCtD
Lubiprostone—Asthenia—Methotrexate—bone cancer	8.6e-05	0.00313	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—bone cancer	8.56e-05	0.00311	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Doxorubicin—bone cancer	8.49e-05	0.00309	CcSEcCtD
Lubiprostone—Hypersensitivity—Epirubicin—bone cancer	8.27e-05	0.00301	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—bone cancer	8.21e-05	0.00299	CcSEcCtD
Lubiprostone—Diarrhoea—Methotrexate—bone cancer	8.21e-05	0.00299	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—bone cancer	8.05e-05	0.00293	CcSEcCtD
Lubiprostone—Dizziness—Methotrexate—bone cancer	7.93e-05	0.00289	CcSEcCtD
Lubiprostone—Diarrhoea—Epirubicin—bone cancer	7.68e-05	0.00279	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—bone cancer	7.65e-05	0.00278	CcSEcCtD
Lubiprostone—Vomiting—Methotrexate—bone cancer	7.63e-05	0.00278	CcSEcCtD
Lubiprostone—Rash—Methotrexate—bone cancer	7.56e-05	0.00275	CcSEcCtD
Lubiprostone—Dermatitis—Methotrexate—bone cancer	7.55e-05	0.00275	CcSEcCtD
Lubiprostone—Headache—Methotrexate—bone cancer	7.51e-05	0.00273	CcSEcCtD
Lubiprostone—Asthenia—Doxorubicin—bone cancer	7.45e-05	0.00271	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—bone cancer	7.42e-05	0.0027	CcSEcCtD
Lubiprostone—Vomiting—Epirubicin—bone cancer	7.14e-05	0.0026	CcSEcCtD
Lubiprostone—Nausea—Methotrexate—bone cancer	7.12e-05	0.00259	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—bone cancer	7.11e-05	0.00259	CcSEcCtD
Lubiprostone—Rash—Epirubicin—bone cancer	7.08e-05	0.00258	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—bone cancer	7.07e-05	0.00257	CcSEcCtD
Lubiprostone—Headache—Epirubicin—bone cancer	7.03e-05	0.00256	CcSEcCtD
Lubiprostone—Dizziness—Doxorubicin—bone cancer	6.87e-05	0.0025	CcSEcCtD
Lubiprostone—Nausea—Epirubicin—bone cancer	6.67e-05	0.00243	CcSEcCtD
Lubiprostone—Vomiting—Doxorubicin—bone cancer	6.6e-05	0.0024	CcSEcCtD
Lubiprostone—Rash—Doxorubicin—bone cancer	6.55e-05	0.00238	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—bone cancer	6.54e-05	0.00238	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—bone cancer	6.51e-05	0.00237	CcSEcCtD
Lubiprostone—Nausea—Doxorubicin—bone cancer	6.17e-05	0.00224	CcSEcCtD
